BSACInurses

Nurses working in the field of atopic disease. Patient advocates. Working with global organisations, other health care professionals to improve allergy care.

[BSACInurses @BSACInurses]

What an inspiring conference! Which sessions did you enjoy the most?

[BSACInurses @BSACInurses]

Allergy nurse special interest group today at #BSACI2026.

[BSACI @BSACI_Allergy]

#BSACI2026 starts today! If you missed out on registering online, you can still register on site when you arrive. Read the programme https://t.co/2bGqVtADB4

[BSACI @BSACI_Allergy]

#BSACI2026: Just around the corner. If you missed online registration, you can still register on-site from Sunday 11th October. Read the programme https://t.co/2bGqVtADB4

[BSACI @BSACI_Allergy]

#BSACI2026: In just over one week, we’re heading to the award-winning ICC, Wales. Don’t miss out! Register online by Sunday 4th October at https://t.co/M2qFivRa1F

[Allergy EAACI @AllergyEaaci]

Allergy provides the readers with 23 free and open access articles in the September issue! Check out the articles and download freely with one click on the doi link.

1. Torres, M.J., Shamji, M., Arasi, S., et al. Decalogue of the Declaration of Salamanca: Advancing Undergraduate Education in Allergy and Clinical Immunology Across Europe. Allergy, 81: 3035-3038. https://t.co/eBtMpvr1fF

2. F. Roth-Walter, I. M. Adcock, C. Benito-Villalvilla, et al., “ Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper,” Allergy 81, no. 9 (2026): 3039–3070, https://t.co/uRrx2QsWkW

3. S. Scheire, E. Lourijsen, M. Blauwblomme, et al., “ Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force,” Allergy 81, no. 9 (2026): 3071–3106, https://t.co/NgbabsFQzX

4. F. E. Gunaydin, G. Marcassa, B. Olivieri, et al., “ Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related Evidence and Predictors,” Allergy 81, no. 9 (2026): 3107–3129, https://t.co/207SxYli3s

5. T. H. Nguyen, C. A. Akdis, A. Baccarelli, et al., “ Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures,” Allergy 81, no. 9 (2026): 3130–3145, https://t.co/Dk1PcRZzoO

6. J. C. Virchow, X. Bertels, V. Backer, et al., “ Remission in Global Airway Diseases: EUFOREA Consensus Paper,” Allergy 81, no. 9 (2026): 3146–3156, https://t.co/BIQke5MsUB

7. S. Gangemi, S. Manti, J. C. Virchow, and G. W. Canonica, “ Targeting Airway Remodeling in Severe Asthma: Is There a Window of Opportunity for Biologic Therapy Predicting Effects Using Causal Artificial Intelligence?,” Allergy 81, no. 9 (2026): 3157–3170, https://t.co/dyM3WUyUeU

8. E. Matsuyama, J. Miyata, T. Mochimaru, et al., “ IL-33 Drives Inflammatory Changes and Extracellular Trap Formation in Eosinophils Involving Oxidised LDL and Complement Pathways,” Allergy 81, no. 9 (2026): 3171–3184, https://t.co/JL1W6QxwQa

9. A. Kumar, R. Chan, N. Zounemat-Kermani, et al., “ Small Airways Dysfunction and Remission in Adults With Asthma: A Longitudinal Exploratory Analysis of the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study,” Allergy 81, no. 9 (2026): 3185–3196, https://t.co/lTaC63u8R3

10. H. Wen, T. Kole, O. A. Carpaij, et al., “ Nasal Airway Transcriptome Reflects Selected Asthma-Associated Gene Signatures in the Lower Airways,” Allergy 81, no. 9 (2026): 3197–3205, https://t.co/IaFH2xMwZd

11. L. I. Andersson, M. Kupczyk, B. Dahlén, et al., “ Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity,” Allergy 81, no. 9 (2026): 3206–3220, https://t.co/xGpGtsOobW

12. P. S. Pathinayake, A. C. Brown, N. T. Awatade, et al., “ Resolving Endoplasmic Reticulum-Protein Misfolding Restores Corticosteroid Sensitivity in Experimental Models of Severe Asthma,” Allergy 81, no. 9 (2026): 3221–3235, https://t.co/3EkNRGjck8

13. A. M. Cannata, J. W. McAlees, J. M. Hargis, et al., “ MAIT Cells Suppress IgE-Mediated Asthma via IFNγ-Dependent B Cell Regulation,” Allergy 81, no. 9 (2026): 3236–3249, https://t.co/d9tg0DkJYq

14. M. E. Wechsler, S. E. Wenzel, S. D. Groshong, et al., “ Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma,” Allergy 81, no. 9 (2026): 3261–3272, https://t.co/90wrCPlHwr

15. W.-J. Song, N. Z. Kermani, A. Versi, et al., “ Clinical Features of Cellular Senescence Pathways in Severe Asthma,” Allergy 81, no. 9 (2026): 3273–3285, https://t.co/BSLycKKhuT

16. F. Yang, S. Seo, T. Hasegawa, et al., “ Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma,” Allergy 81, no. 9 (2026): 3286–3299, https://t.co/YW0tiharaA

17. J. Shen, R. Chaudhuri, S. Bicknell, et al., “ The Airway Transcriptome in Type 2 Cytokine Biomarker-High and -Low Severe Asthma,” Allergy 81, no. 9 (2026): 3300–3317, https://t.co/Pq4oU1DT4l

18. J. D. Hamilton, M. A. R. Ferreira, W. K. Lim, et al., “ Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade,” Allergy 81, no. 9 (2026): 3345–3360, https://t.co/MfXqMVREIh

19. H.-C. Chang, M.-C. Wu, T. Zuberbier, and S.-Y. Gau, “ Anxiety, Depression, Schizophrenia, and Bipolar Disorder in Eosinophilic Esophagitis Patients: A Global Federated Cohort Analysis of Bidirectional Risks,” Allergy 81, no. 9 (2026): 3361–3364, https://t.co/0X6NwvZfPs

20. M. C. Melles, J. C. C. M. Veen, D.-J. Slebos, et al., “ Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations,” Allergy 81, no. 9 (2026): 3365–3367, https://t.co/QJslsFup8H

21. C. Handoko, A. Singh, S. C. Dharmage, et al., “ The Impact of Early Childhood Caries on Asthma Trajectories During the First 15 Years of Life,” Allergy 81, no. 9 (2026): 3368–3371, https://t.co/ythJujMEVD

22. J. Bernaola, J. A. Cañas, Á. Arranz-Fragua, et al., “ Differential Effects of Benralizumab and Mepolizumab on Pro-Resolving Mediators,” Allergy 81, no. 9 (2026): 3377–3383, https://t.co/j3XIOAX38l

23. P.-H. Lee, S. Yoon, C. Lee, and A.-S. Jang, “ Moesin, a Cytoskeletal-Associated Protein, Outperforms Candidate Biomarkers in Identifying Asthma Exacerbation,” Allergy 81, no. 9 (2026): 3384–3386, https://t.co/EGK4Ho8bPY

#Allergy_journal
Read all recent papers published in #Allergy here: https://t.co/WsHBrsUyhR

[BSACI @BSACI_Allergy]

BSACI Webinar Food Challenges - a practical approach based on the BSACI Clinical Practice Statement, Monday 14th September, 5-6pm. Register now https://t.co/c1OiiwSphe

[BSACI @BSACI_Allergy]

BSACI Webinar Food Challenges - a practical approach based on the BSACI Clinical Practice Statement, Monday 14th September, 5-6pm. Register now https://t.co/c1OiiwRRrG

[BSACI @BSACI_Allergy]

#BSACI2026: Endotypes in childhood asthma. Sejal Saglani will reveal optimal biomarker tests to improve treatment choice for preschool wheeze and difficult asthma https://t.co/0oD9twgvni

[BSACInurses @BSACInurses]

Great start to the BSACI Allied Health Professionals Annual Virtual Training Day!
Some interesting cases @AllergicToDiets presented wonderfully by Hannah!

[BSACI @BSACI_Allergy]

BSACI Allied Health Professionals Online Annual Training Day, Wednesday 1st July. Free for members, £25 for non-members. Book your place https://t.co/yJgzA4Id23

[BSACI @BSACI_Allergy]

#BSACI2026: Late-breaking Abstract submissions is OPEN. This final submission window closes at 08:00 on Monday 29th June. Submit now https://t.co/nCSmKFgOLf

[EAACI @EAACI_HQ]

🎥 Day 4 in 60 seconds.

Reflection. Collaboration. Legacy.

The final day of EAACI Congress 2026 brought our global community together to celebrate a week of scientific excellence, meaningful connections, and shared purpose.

🔬 From discussions on planetary health and the future of asthma care to conversations on scientific integrity and emerging clinical insights, Day 4 highlighted the impact of collaboration in advancing allergy and clinical immunology.

🏆 As we closed another unforgettable Congress and celebrated 70 years of EAACI, we reflected on the achievements, discoveries, and partnerships that continue to shape our field.

✨ Watch the highlights and relive the moments that defined #EAACICongress2026.

🌍 Vision Zero: A Future Free from Allergy and Asthma Burden.

#EAACICongress2026 #EAACI #VisionZero #Allergy #Asthma #ClinicalImmunology #Immunology #Healthcare #MedicalResearch #PatientCare #MedicalCongress #ScientificExchange #GlobalHealth #Innovation

[EAACI @EAACI_HQ]

🎥 Day 3 in 60 seconds.

Innovation. Exchange. Progress.

EAACI Congress 2026 continued in Istanbul with another inspiring day of scientific discovery, meaningful conversations, and global collaboration.

From groundbreaking discussions on precision medicine and targeted therapies to thought-provoking talks, leadership engagement, and patient-centred perspectives, Day 3 highlighted the ideas and partnerships shaping the future of allergy and clinical immunology.

Watch the highlights and experience the momentum of #EAACICongress2026. ✨

🌍 Vision Zero: A Future Free from Allergy and Asthma Burden.

#EAACI #Allergy #Asthma #ClinicalImmunology #Immunology #MedicalCongress #Healthcare #Research #Istanbul

[EAACI @EAACI_HQ]

🎥 Day 2 in 60 seconds.

Energy ✔️
Innovation ✔️
Connection ✔️

From early morning activities to inspiring scientific sessions and valuable networking opportunities, Day 2 of EAACI Congress 2026 brought our global community together to learn, collaborate and shape the future of allergy and clinical immunology.

Watch the highlights and experience another remarkable day in Istanbul at #EAACICongress2026

🌍 Vision Zero: A Future Free from Allergy and Asthma Burden.

#EAACI #Allergy #Asthma #ClinicalImmunology #Immunology #MedicalCongress #Healthcare #Research #Istanbul

[EAACI @EAACI_HQ]

🌍 EAACI Congress 2026 | Day 1 Highlights

EAACI Congress 2026 has officially begun in Istanbul, bringing together the global allergy and clinical immunology community under this year's theme:

✨ Vision Zero: A Future Free from Allergy and Asthma Burden

From the Opening Ceremony and EAACI Awards to inspiring scientific sessions, interactive experiences and meaningful networking opportunities, Day 1 was filled with learning, collaboration and innovation.

Watch the highlights from an exciting first day and experience the energy, science and community that make the EAACI Congress the world's leading meeting in allergy and clinical immunology.

📍 Istanbul, Türkiye
📅 12–15 June 2026

#EAACICongress2026 #EAACI2026 #VisionZero #Allergy #Asthma #ClinicalImmunology #Immunology #MedicalCongress #Healthcare #Research #Istanbul

[BSACInurses @BSACInurses]

The Challenges of Oral Tolerance Induction in a Diverse Population Advised to Introduce Allergens Early: Insights From the EarlyNuts Study
https://t.co/pvd7IHxT5b
#earlyintroduction #foodallergy @BDA_Dietitians @ARNS_UK

[BSACI @BSACI_Allergy]

Share Your Voice and complete the National Allergy Strategy Group survey by 15th November 2024 https://t.co/lSEuy8wbZb @AllergyCampaign

[George du Toit @GoAllergy]

No evidence nut allergens spread via aircraft ventilation systems, study finds https://t.co/VOSiO1iWnb

[Graham Roberts @ProfGRoberts]

We are looking for input from young people living with food allergy, their parents and healthcare professionals. What things don't we understand about food allergy? What are the research priorities? Please find the survey at: https://t.co/BhsAgg4pe2. @riddmj